457 related articles for article (PubMed ID: 32648592)
1. COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use.
Arca KN; Smith JH; Chiang CC; Starling AJ; Robertson CE; Halker Singh RB; Schwedt TJ; Kissoon NR; Garza I; Rozen TD; Boes CJ; Whealy MA; VanderPluym JH
Headache; 2020 Sep; 60(8):1558-1568. PubMed ID: 32648592
[TBL] [Abstract][Full Text] [Related]
2. Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group.
Morollón N; Belvís R; De Dios A; Pagès N; González-Oria C; Latorre G; Santos-Lasaosa S
Neurologia (Engl Ed); 2020; 35(9):628-632. PubMed ID: 32896463
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy in COVID-19; A narrative review for emergency providers.
Mehta N; Mazer-Amirshahi M; Alkindi N; Pourmand A
Am J Emerg Med; 2020 Jul; 38(7):1488-1493. PubMed ID: 32336586
[TBL] [Abstract][Full Text] [Related]
4. [Drugs that aggravate the course of COVID-19 : really ?].
Rothuizen LE; Livio F; Buclin T
Rev Med Suisse; 2020 Apr; 16(N° 691-2):852-854. PubMed ID: 32348052
[TBL] [Abstract][Full Text] [Related]
5. Topical steroids and topical tacrolimus appear safe regarding the COVID-19 epidemic.
Souaid K; Klejtman T; Kramkimel N; Isnard C; Dupin N; Aractingi S
Ann Dermatol Venereol; 2021 Jun; 148(2):122-123. PubMed ID: 33551212
[No Abstract] [Full Text] [Related]
6. Corticosteroid administration for viral pneumonia: COVID-19 and beyond.
Yang JW; Yang L; Luo RG; Xu JF
Clin Microbiol Infect; 2020 Sep; 26(9):1171-1177. PubMed ID: 32603802
[TBL] [Abstract][Full Text] [Related]
7. A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality.
Smart L; Fawkes N; Goggin P; Pennick G; Rainsford KD; Charlesworth B; Shah N
Inflammopharmacology; 2020 Oct; 28(5):1141-1152. PubMed ID: 32797326
[TBL] [Abstract][Full Text] [Related]
8. Use of Nonsteroidal Anti-inflammatory Drugs for COVID-19 Infection: Adjunct Therapy?
Zhao D; Zhang S; Igawa T; Frishman W
Cardiol Rev; 2020; 28(6):303-307. PubMed ID: 33017365
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?
Kutti Sridharan G; Kotagiri R; Chandiramani VH; Mohan BP; Vegunta R; Vegunta R; Rokkam VRP
Am J Ther; 2020; 27(4):e400-e402. PubMed ID: 32366740
[TBL] [Abstract][Full Text] [Related]
10. Increased susceptibility of SARS-CoV2 infection on oral cancer patients; cause and effects: An hypothesis.
Chauhan A; Ghoshal S; Pal A
Med Hypotheses; 2020 Nov; 144():109987. PubMed ID: 32562913
[TBL] [Abstract][Full Text] [Related]
11. The Use of Pharmacological Preventive Therapy for Migraine With Weight Gain Potential Amid Coronavirus Disease 2019 Pandemic.
Kow CS; Hasan SS
Headache; 2020 Oct; 60(9):2085-2086. PubMed ID: 32790208
[No Abstract] [Full Text] [Related]
12. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
[TBL] [Abstract][Full Text] [Related]
13. Comparative tolerability of treatments for inflammatory bowel disease.
Stein RB; Hanauer SB
Drug Saf; 2000 Nov; 23(5):429-48. PubMed ID: 11085348
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
15. Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019.
Timberlake DT; Strothman K; Grayson MH
Curr Opin Allergy Clin Immunol; 2021 Apr; 21(2):182-187. PubMed ID: 33399389
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 and Headache: A Primer for Trainees.
Bobker SM; Robbins MS
Headache; 2020 Sep; 60(8):1806-1811. PubMed ID: 32521039
[TBL] [Abstract][Full Text] [Related]
17. The Ineluctable Role of ACE-2 Receptors in SARS COV-2 Infection and Drug Repurposing as a Plausible SARS COV-2 Therapy: A Concise Treatise.
Joseph S; Nair B; Nath LR
Curr Mol Med; 2021; 21(10):888-913. PubMed ID: 33563197
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 in patients with inflammatory bowel disease.
Anikhindi SA; Kumar A; Arora A
Expert Rev Gastroenterol Hepatol; 2020 Dec; 14(12):1187-1193. PubMed ID: 32856955
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic.
Noreen S; Maqbool I; Madni A
Eur J Pharmacol; 2021 Mar; 894():173854. PubMed ID: 33428898
[TBL] [Abstract][Full Text] [Related]
20. Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection.
Micallef J; Soeiro T; Jonville-Béra AP;
Therapie; 2020; 75(4):355-362. PubMed ID: 32418728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
